Cargando…

The Usefulness of Prognostic Tools in Breast Cancer Patients with Brain Metastases

SIMPLE SUMMARY: Due to the variability of an individual’s prognosis and the variety of treatment options available to breast cancer (BC) patients with brain metastases (BM), establishing the proper therapy is challenging. Since 1997, several prognostic tools for BC patients with BM have been propose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kufel-Grabowska, Joanna, Niwińska, Anna, Radecka, Barbara S., Ali, Shan, Mandat, Tomasz, Duchnowska, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909185/ https://www.ncbi.nlm.nih.gov/pubmed/35267407 http://dx.doi.org/10.3390/cancers14051099

Ejemplares similares

Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy
por: Niwinska, Anna, et al.
Publicado: (2022)

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
por: Duchnowska, Renata, et al.
Publicado: (2012)

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis
por: Duchnowska, Renata, et al.
Publicado: (2016)

Salvage Treatment for Progressive Brain Metastases in Breast Cancer
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022)

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients
por: Winczura, Piotr, et al.
Publicado: (2015)

Molecular Profiles of Brain Metastases: A Focus on Heterogeneity
por: Ali, Shan, et al.
Publicado: (2021)

Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases
por: Duchnowska, Renata, et al.
Publicado: (2022)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
por: Żok, Jolanta, et al.
Publicado: (2021)

Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

Prognostic scores in brain metastases from breast cancer
por: Nieder, Carsten, et al.
Publicado: (2009)

Deep Brain Stimulation for Movement Disorders
por: Pizzolato, Gilberto, et al.
Publicado: (2012)

Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer
por: Hryciuk, Beata, et al.
Publicado: (2020)

Assessment of the usefulness of prognostic Van Nuys Prognostic Index in the treatment in ductal carcinoma in situ in 15-year observation
por: Kunkiel, Michał, et al.
Publicado: (2021)

Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
por: Niwińska, Anna, et al.
Publicado: (2013)

Deep brain stimulation for refractory epilepsy
por: Tykocki, Tomasz, et al.
Publicado: (2012)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease
por: Tykocki, Tomasz, et al.
Publicado: (2011)

Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool
por: Weykamp, Fabian, et al.
Publicado: (2020)

Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022)

Seasonal influenza vaccination among cancer patients during the COVID-19 pandemic in Poland
por: Bartoszkiewicz, Mikolaj, et al.
Publicado: (2021)

Recurrent pyoderma gangrenosum precipitated by breast cancer: a case report and review of the literature
por: Duchnowska, Renata, et al.
Publicado: (2014)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
por: Niwińska, Anna, et al.
Publicado: (2021)

Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases
por: Braccini, Antoine-Laurent, et al.
Publicado: (2013)

Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis
por: Wu, Zhuoyi, et al.
Publicado: (2022)

Patient Eligibility and Results for Brain Metastasis in Phase 3 Trials of Advanced Breast Cancer: A Scoping Review
por: Duchnowska, Renata, et al.
Publicado: (2021)

Periaqueductal/periventricular gray deep brain stimulation for the treatment of neuropathic facial pain
por: Mandat, Victor, et al.
Publicado: (2023)

Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer
por: Okada, Yukinori, et al.
Publicado: (2020)

Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on the Lipid Profile in Patients With Parkinson's Disease
por: Samborska-Ćwik, Joanna, et al.
Publicado: (2020)

Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin
por: Szmit, Sebastian, et al.
Publicado: (2020)

Methods and results of local treatment of brain metastases in patients with breast cancer
por: Szadurska, Agnieszka, et al.
Publicado: (2017)

Utility of a prognostic assessment tool to predict survival following surgery for brain metastases
por: Cuthbert, Hadleigh, et al.
Publicado: (2023)

Prognostic factors of brain metastases from colorectal cancer
por: Imaizumi, Jun, et al.
Publicado: (2019)

Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients
por: Pogoda, Katarzyna, et al.
Publicado: (2013)

ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases
por: Tsakonas, Georgios, et al.
Publicado: (2020)

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
por: Nicoś, Marcin, et al.
Publicado: (2022)

Common low-penetrance risk variants associated with breast cancer in Polish women
por: Ledwoń, Joanna K, et al.
Publicado: (2013)

Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
por: Duchnowska, Renata, et al.
Publicado: (2017)

Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases
por: Bottosso, Michele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e7s7f1gnoa6pass449a8p9v7mh